Literature DB >> 1722764

Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-gamma antibody.

T W Kay1, I L Campbell, L Oxbrow, L C Harrison.   

Abstract

Overexpression of class I major histocompatibility complex (MHC) proteins on pancreatic islet cells is a characteristic of autoimmune Type 1 (insulin-dependent) diabetes mellitus in humans and in animal models. Studies of post-mortem pancreases from humans with Type 1 diabetes suggest that overexpression of class I MHC proteins may precede mononuclear cell infiltration of the islets (insulitis). Pancreatic histology from the earliest stages of human Type 1 diabetes is rarely available. We have used the non-obese diabetic mouse, given cyclophosphamide to accelerate Beta-cell destruction, to investigate the temporal relationship between the overexpression of class I MHC protein and mRNA and other pathological changes associated with Beta-cell destruction. Prior to cyclophosphamide, immunoperoxidase staining showed that expression of class I MHC proteins was greater on islet cells and infiltrating inflammatory cells of the non-obese diabetic mouse than on islet cells of other mouse strains, whereas staining on exocrine cells was similar. On day three after cyclophosphamide administration, when insulitis had regressed, islet class I MHC protein expression had diminished. A dramatic increase in class I MHC protein expression occurred between days seven and nine, concomitant with reinfiltration of the islets by mononuclear cells; overexpression was seen both on islet cells and on surrounding exocrine cells, but only in the presence of mononuclear cell infiltration. By day 21, class I MHC protein overexpression was again confined to the islets, the exocrine pancreas being free of infiltration. Class I mRNA also increased dramatically by day eight but had virtually returned to normal by day 12.2+ effected by cytokines secreted by activated immuno-inflammatory cells. Class I MHC overexpression should enhance targeting of cytotoxic T cells to Beta cells bearing autoantigen.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722764     DOI: 10.1007/bf00408350

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  40 in total

1.  Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice.

Authors:  R Yasunami; J F Bach
Journal:  Eur J Immunol       Date:  1988-03       Impact factor: 5.532

2.  Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes.

Authors:  J A Shizuru; C Taylor-Edwards; B A Banks; A K Gregory; C G Fathman
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

3.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.

Authors:  V T Oi; P P Jones; J W Goding; L A Herzenberg; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

Review 4.  Role of the major histocompatibility complex class I antigens in tumor growth and metastasis.

Authors:  K Tanaka; T Yoshioka; C Bieberich; G Jay
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

5.  Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression.

Authors:  L A O'Reilly; P R Hutchings; P R Crocker; E Simpson; T Lund; D Kioussis; F Takei; J Baird; A Cooke
Journal:  Eur J Immunol       Date:  1991-05       Impact factor: 5.532

6.  Interferon-gamma induces transcription and differential expression of MHC genes in rat insulinoma cell line RINm5F.

Authors:  S J Ono; E Colle; R D Guttmann; A Fuks
Journal:  Diabetes       Date:  1989-07       Impact factor: 9.461

7.  Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice.

Authors:  T Koike; Y Itoh; T Ishii; I Ito; K Takabayashi; N Maruyama; H Tomioka; S Yoshida
Journal:  Diabetes       Date:  1987-04       Impact factor: 9.461

8.  Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice.

Authors:  B J Miller; M C Appel; J J O'Neil; L S Wicker
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

9.  Interferon-gamma enhances the expression of the major histocompatibility class I antigens on mouse pancreatic beta cells.

Authors:  I L Campbell; G H Wong; J W Schrader; L C Harrison
Journal:  Diabetes       Date:  1985-11       Impact factor: 9.461

10.  Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.

Authors:  A Bendelac; C Carnaud; C Boitard; J F Bach
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  14 in total

1.  Interferon-α mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes.

Authors:  Laura Marroqui; Reinaldo S Dos Santos; Anne Op de Beeck; Alexandra Coomans de Brachène; Lorella Marselli; Piero Marchetti; Decio L Eizirik
Journal:  Diabetologia       Date:  2017-01-06       Impact factor: 10.122

Review 2.  The immunologic insult in type 1 diabetes.

Authors:  M C Honeyman; L C Harrison
Journal:  Springer Semin Immunopathol       Date:  1993

3.  B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells.

Authors:  Jun Sik Lee; Lisa Scandiuzzi; Anjana Ray; Joyce Wei; Kimberly A Hofmeyer; Yael M Abadi; P'ng Loke; Juan Lin; Jianda Yuan; David V Serreze; James P Allison; Xingxing Zang
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

4.  IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes.

Authors:  H E Thomas; J L Parker; R D Schreiber; T W Kay
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

5.  NOD mice are defective in proteasome production and activation of NF-kappaB.

Authors:  T Hayashi; D Faustman
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

6.  Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.

Authors:  N Itoh; T Hanafusa; A Miyazaki; J Miyagawa; K Yamagata; K Yamamoto; M Waguri; A Imagawa; S Tamura; M Inada
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

Review 7.  Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.

Authors:  Ayelet Kaminitz; Shifra Ash; Nadir Askenasy
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

8.  Level of major histocompatibility complex class I expression on endothelium in non-obese diabetic mice influences CD8 T cell adhesion and migration.

Authors:  B Lozanoska-Ochser; M Peakman
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

Review 9.  Viral infections in type 1 diabetes mellitus--why the β cells?

Authors:  Anne Op de Beeck; Decio L Eizirik
Journal:  Nat Rev Endocrinol       Date:  2016-03-29       Impact factor: 43.330

10.  In vivo expression of MHC class I genes depends on the presence of a downstream barrier element.

Authors:  Helit Cohen; Palak Parekh; Zeynep Sercan; Aparna Kotekar; Jocelyn D Weissman; Dinah S Singer
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.